KalVista Pharmaceuticals, Inc.

LOS ANGELES CAPITAL MANAGEMENT LLC KALV

Report date

3/31/2026

Quarter

2026 Q1

Filed

5/8/2026

Shares

732

Value ($000)

15

Weight

0.0%

2021 Q2 - 2026 Q1 (4 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q1	5/8/2026	15	0.0%	732	3/31/2026
2023 Q2	8/3/2023	653	0.0%	72,540	6/30/2023
2021 Q3	11/8/2021	318	0.0%	18,229	9/30/2021
2021 Q2	8/5/2021	481	0.0%	20,079	6/30/2021